The University of Melbourne

Researchers

• CLChristine Y Lu
• JYJustin Yeung
• MRMeena Rafiq
• RMRoger L Milne

Running trials

• Not yet recruiting

  An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function

  NCT07613398· Matthias Stuber· Source

• Recruiting

  Closed Loop and Education for Hypoglycemia Awareness Restoration

  NCT06325202· Milton S. Hershey Medical Center· Source

• Recruiting

  A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE

  NCT07118241· Phase 2· Lubris Bio Pty Ltd· Source

• Recruiting

  Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?

  NCT06940596· University of Melbourne· Source

• Recruiting

  Closed-loop in Adults With Type 2 Diabetes

  NCT06579404· University of Cambridge· Source

• Recruiting

  Silexan in the Treatment Of Posttraumatic Stress Disorder Trial

  NCT06412757· Phase 3· Deakin University· Source

• Recruiting

  Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  NCT04124120· Weill Medical College of Cornell University· Source

• Recruiting

  Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease

  NCT05136222· University of Melbourne· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)1 recruiting
• Congenital heart disease1 recruiting
• Coronary artery disease1 recruiting
• Irritable bowel syndrome1 recruiting
• Sjögren's disease1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  NCT06524830· Phase 2· atai Therapeutics, Inc.· Source

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· Phase 3· ModernaTX, Inc.· Source

• Completed

  Effects of a Weight Loss Program in People With Hip Osteoarthritis

  NCT04825483· University of Melbourne· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke268 works · 0 trials
• Alzheimer disease193 works · 0 trials
• Obesity172 works · 1 trial
• Epilepsy164 works · 0 trials
• Prostate cancer145 works · 0 trials
• Lung cancer133 works · 0 trials
• Schizophrenia116 works · 0 trials
• HIV105 works · 0 trials
• Osteoarthritis103 works · 1 trial
• Heart failure103 works · 0 trials
• Colorectal cancer103 works · 0 trials
• Type 2 diabetes95 works · 1 trial
• Atrial fibrillation91 works · 0 trials
• Asthma88 works · 0 trials
• Multiple sclerosis88 works · 0 trials
• Depression76 works · 1 trial
• Tuberculosis75 works · 0 trials
• Multiple myeloma66 works · 0 trials
• Bipolar disorder65 works · 0 trials
• Chronic kidney disease64 works · 0 trials
• Melanoma60 works · 0 trials
• Type 1 diabetes58 works · 1 trial
• Mild cognitive impairment52 works · 0 trials
• Ovarian cancer48 works · 0 trials
• Hearing loss47 works · 0 trials
• COPD46 works · 0 trials
• Glaucoma45 works · 0 trials
• Autism43 works · 0 trials
• Cervical cancer42 works · 0 trials
• Deep vein thrombosis and pulmonary embolism42 works · 0 trials